Please Wait
Applying Filters...
menu
    • menu
    Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

    Data Compilation
    #PharmaFlow

    Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

    Stock Recap
    #PipelineProspector

    Menu

    Vortioxetine Hydrobromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,111Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    27/09/2025 Alembic Pharmaceuticals Limited
    India
    		 Seongwoo Chemical Co., Ltd. Su473-29-ND Vortioxetine hydrobromide 2022-09-16 Alembic Pharmaceuticals Limited (API Unit-lll) India API Division Karakhadi, Plot No. 842-843 Tal-Padra, AT.- Karakhadi-391 450, Dist.- Vadodara, Gujarat State, India.
    27/09/2025 H. Lundbeck AS
    Denmark
    		 Lundbeck Korea Ltd. Su4496-3-ND Vortioxetine hydrobromide 2014-07-24 H. Lundbeck A/S@Jetpharma SA@Lundbeck Pharmaceuticals Italy SPA Denmark Oddenvej 182, Lumsas 4500 Nykøbing Sjælland, Denmark@Via Sottobisio 42 A, 6828 Balerna, Switzerland@Viale dell'Industria, 54 - 35129, Padova (PD), Italy